CSIMarket
 


Presbia Plc  (LENS)
Other Ticker:  
 

Presbia Plc's Quick Ratio

LENS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Presbia Plc's Cash & cash equivalent grew by 76.96 % in the IV Quarter 2018 sequentially, while Current Liabilities decreased, this led to improvement in Presbia Plc's Quick Ratio to 2.62, Quick Ratio remained below Presbia Plc average.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Quick Ratio than Presbia Plc in forth quarter 2018. While Quick Ratio total ranking has improved so far during the IV Quarter 2018 to 1023, from total ranking in the third quarter 2018 at 1031.

Explain Quick Ratio?
How much Cash & cash equivalents LENS´s has?
What are LENS´s Current Liabilities?


LENS Quick Ratio (Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Change -57.71 % -35.8 % -23.73 % 2.37 % 53.26 %
Y / Y Cash & cash equivalent Change -21.91 % -79.77 % -68.8 % -92.89 % -55.87 %
Quick Ratio MRQ 2.62 0.88 1.92 0.44 1.42
LENS's Total Ranking # 1023 # 1031 # 1098 # 2111 # 1418
Seq. Current Liabilities Change -40.54 % -6.29 % -27.07 % 4.08 % -9.73 %
Seq. Cash & cash equivalent Change 76.96 % -57.09 % 216.35 % -67.49 % -54.16 %



Quick Ratio forth quarter 2018 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 50
Healthcare Sector # 443
Overall Market # 1023


Quick Ratio Statistics
High Average Low
15.99 7.08 0.44
(Dec 31 2015)   (Mar 31 2018)




Financial Statements
Presbia Plc's Current Liabilities $ 1 Millions Visit LENS's Balance sheet
Presbia Plc's Cash & cash equivalent $ 3 Millions Visit LENS's Balance sheet
Source of LENS's Sales Visit LENS's Sales by Geography


Cumulative Presbia Plc's Quick Ratio

LENS's Quick Ratio for the trailling 12 Months

LENS Quick Ratio

(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities TTM Growth -57.71 % -35.8 % -23.73 % 2.37 % 53.26 %
Y / Y Cash & cash equivalent TTM Growth -21.91 % -79.77 % -68.8 % -92.89 % -55.87 %
Quick Ratio TTM 1.24 1.13 1.65 2.33 3.8
Total Ranking TTM # 1498 # 1492 # 1161 # 900 # 591
Seq. Current Liabilities TTM Growth -40.54 % -6.29 % -27.07 % 4.08 % -9.73 %
Seq. Cash & cash equivalent TTM Growth 76.96 % -57.09 % 216.35 % -67.49 % -54.16 %


On the trailing twelve months basis Current Liabilities decreased faster than Presbia Plc's average Cash & cash equivalent, this led to increase in in Presbia Plc's Quick Ratio to 1.24, Quick Ratio remained below LENS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 189 other companies have achieved higher Quick Ratio than Presbia Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2018 from 1195 to 4910.

Explain Quick Ratio?
How much Cash & cash equivalents LENS´s has?
What are LENS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 190
Healthcare Sector # 857
Within the Market # 1023


trailing twelve months Quick Ratio Statistics
High Average Low
13.55 6.8 1.13
(Mar 31 2016)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Dec 31 2018, within Medical Equipment & Supplies Industry Quick RatioDec 31 2018 MRQ Cash & cash equivalentDec 31 2018 MRQ Current Liabilities
Atrion Corporation  7.13 $ 68.437  Millions$ 9.601  Millions
Orthopediatrics Corp  6.58 $ 60.691  Millions$ 9.217  Millions
Adynxx, Inc.  6.45 $ 8.880  Millions$ 1.376  Millions
Orasure Technologies Inc  6.40 $ 156.572  Millions$ 24.459  Millions
Iradimed Corporation  5.98 $ 28.028  Millions$ 4.690  Millions
Abiomed Inc   5.88 $ 458.156  Millions$ 77.900  Millions
Inogen Inc   5.16 $ 240.349  Millions$ 46.585  Millions
Asensus Surgical Inc   5.16 $ 72.851  Millions$ 14.124  Millions
Dexcom Inc   5.11 $ 1,137.000  Millions$ 222.400  Millions
Intersect Ent Inc   5.11 $ 100.773  Millions$ 19.733  Millions
Glaukos Corp  4.92 $ 149.263  Millions$ 30.365  Millions
Nuvectra Corp  4.83 $ 99.240  Millions$ 20.544  Millions
Perspective Therapeutics Inc   4.80 $ 7.868  Millions$ 1.640  Millions
Nevro Corp   4.24 $ 264.547  Millions$ 62.414  Millions
Pro dex Inc   4.00 $ 10.713  Millions$ 2.675  Millions
Novocure Limited  3.81 $ 245.878  Millions$ 64.560  Millions
Alpha Pro Tech Ltd   3.78 $ 7.265  Millions$ 1.920  Millions
Staar Surgical Company  3.75 $ 103.877  Millions$ 27.728  Millions
Masimo Corp  3.74 $ 552.490  Millions$ 147.607  Millions
Intuitive Surgical Inc   3.73 $ 3,063.100  Millions$ 820.600  Millions
Biosig Technologies Inc   3.72 $ 4.450  Millions$ 1.198  Millions
Quoin Pharmaceuticals Ltd   3.64 $ 17.809  Millions$ 4.899  Millions
Nemaura Medical Inc   3.57 $ 5.041  Millions$ 1.411  Millions
Globus Medical Inc   3.53 $ 339.584  Millions$ 96.118  Millions
Myomo Inc   3.52 $ 6.541  Millions$ 1.856  Millions
Inspiremd Inc   3.21 $ 9.384  Millions$ 2.920  Millions
Viewray Inc   3.11 $ 167.432  Millions$ 53.889  Millions
Atricure Inc   3.09 $ 124.402  Millions$ 40.216  Millions
Cardiovascular Systems Inc   3.06 $ 119.206  Millions$ 38.989  Millions
Penumbra Inc   3.04 $ 200.889  Millions$ 66.062  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com